Search Results - "Asmar, Meena"

Refine Results
  1. 1
  2. 2

    The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action by HARE, Kristine J, VILSBØLL, Tina, ASMAR, Meena, DEACON, Carolyn F, KNOP, Filip K, HOLST, Jens J

    Published in Diabetes (New York, N.Y.) (01-07-2010)
    “…Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic beta- and alpha-cells. Previous studies have focused on the…”
    Get full text
    Journal Article
  3. 3

    Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men by Asmar, Ali, Simonsen, Lene, Asmar, Meena, Madsbad, Sten, Holst, Jens J, Frandsen, Erik, Moro, Cedric, Jonassen, Thomas, Bülow, Jens

    “…The present experiments were performed to elucidate the acute effects of intravenous infusion of glucagon-like peptide (GLP)-1 on central and renal…”
    Get more information
    Journal Article
  4. 4

    Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans by ASMAR, Meena, SIMONSEN, Lene, MADSBAD, Sten, STALLKNECHT, Bente, JUUL HOLST, Jens, BÜLOW, Jens

    Published in Diabetes (New York, N.Y.) (01-09-2010)
    “…Glucose-dependent insulinotropic polypeptide (GIP) has been implicated in lipid metabolism in animals. In humans, however, there is no clear evidence of GIP…”
    Get full text
    Journal Article
  5. 5

    GIP-induced vasodilation in human adipose tissue involves capillary recruitment by Asmar, Meena, Asmar, Ali, Simonsen, Lene, Dela, Flemming, Holst, Jens Juul, Bülow, Jens

    Published in Endocrine Connections (01-06-2019)
    “…Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia increase blood flow and triglyceride clearance in subcutaneous…”
    Get full text
    Journal Article
  6. 6

    Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes Mellitus by Hare, Kristine J., Knop, Filip K., Asmar, Meena, Madsbad, Sten, Deacon, Carolyn F., Holst, Jens J., Vilsbøll, Tina

    “…Objective: Glucagon-like peptide-1 (GLP-1) is insulinotropic, but its effect on the α-cell is less clear. We investigated the dose-response relationship for…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Searching for the physiological role of glucose‐dependent insulinotropic polypeptide by Holst, Jens Juul, Windeløv, Johanne Agerlin, Boer, Geke Aline, Pedersen, Jens, Svendsen, Berit, Christensen, Mikkel, Torekov, Signe, Asmar, Meena, Hartmann, Bolette, Nissen, Anne

    Published in Journal of diabetes investigation (01-04-2016)
    “…Glucose‐dependent insulinotropic polypeptide (GIP) was established as a gut hormone more than 40 years ago, and there is good experimental support for its role…”
    Get full text
    Journal Article
  9. 9

    Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP‐1 but not GIP, CCK, and gastrin in plasma by Asmar, Ali, Cramon, Per K., Asmar, Meena, Simonsen, Lene, Sorensen, Charlotte M., Madsbad, Sten, Moro, Cedric, Hartmann, Bolette, Rehfeld, Jens F., Holst, Jens J., Hovind, Peter, Jensen, Boye L., Bülow, Jens

    Published in Physiological reports (01-08-2020)
    “…Human studies have demonstrated that physiologically relevant changes in circulating glucagon‐like peptide‐1 (GLP‐1) elicit a rapid increase in renal sodium…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans by Asmar, Meena, Simonsen, Lene, Asmar, Ali, Holst, Jens Juul, Dela, Flemming, Bülow, Jens

    “…Context and Objective: Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia increases blood flow and triglyceride (TAG)…”
    Get full text
    Journal Article
  12. 12

    1957-P: The Role of Glucose-Dependent Insulinotropic Polypeptide in Regulation of Splanchnic Blood Flow and Lipid Metabolism in Humans by ASMAR, ALI, HOLST, JENS J., ASMAR, MEENA

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…The aim of this study was to investigate the effect of glucose-dependent insulinotropic polypeptide (GIP) per se and in combination with hyperglycemia and…”
    Get full text
    Journal Article
  13. 13

    Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs? by Rehfeld, Jens F., Knop, Filip K., Asmar, Meena

    Published in Scandinavian journal of gastroenterology (02-12-2019)
    “…Background: Randomized and controlled trials of glucagon-like peptide-1 (GLP-1) derived drugs have shown that the most frequent adverse symptoms are…”
    Get full text
    Journal Article
  14. 14

    Glucose-dependent insulinotropic polypeptide increases blood flow in adipose tissue of humans by recruiting capillaries by Asmar, Meena, Asmar, Ali, Simonsen, Lene, Holst, Jens Juul, Bülow, Jens

    “…Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia increase blood flow and triglyceride clearance in subcutaneous…”
    Get full text
    Journal Article
  15. 15

    Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs by Rehfeld, Jens F, Knop, Filip K, Asmar, Ali, Madsbad, Sten, Holst, Jens J, Asmar, Meena

    Published in Scandinavian journal of gastroenterology (02-12-2018)
    “…Recent randomized and controlled trials of drugs derived from the gut hormone glucagon-like peptide-1 (GLP-1) show that the most frequent adverse symptoms are…”
    Get full text
    Journal Article
  16. 16

    Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1: A Functional GLP-1–Renal Axis in Man by Asmar, Ali, Cramon, Per K, Simonsen, Lene, Asmar, Meena, Sorensen, Charlotte M, Madsbad, Sten, Moro, Cedric, Hartmann, Bolette, Jensen, Boye L, Holst, Jens J, Bülow, Jens

    “…Abstract Purpose We have previously demonstrated that glucagon-like peptide-1 (GLP-1) does not affect renal hemodynamics or function under baseline conditions…”
    Get full text
    Journal Article
  17. 17

    The Renal Extraction and the Natriuretic Action of GLP-1 in Humans Depend on Interaction With the GLP-1 Receptor by Asmar, Ali, Cramon, Per K, Asmar, Meena, Simonsen, Lene, Sorensen, Charlotte M, Madsbad, Sten, Hartmann, Bolette, Holst, Jens J, Hovind, Peter, Jensen, Boye L, Bülow, Jens

    “…Abstract Purpose The natriuretic effect of glucagon-like peptide-1 (GLP-1) in humans is independent of changes in renal plasma flow (RPF) and glomerular…”
    Get full text
    Journal Article
  18. 18

    WITHDRAWN: Glucose-Dependent Insulinotropic Polypeptide Increases Blood Flow in Adipose Tissue of Humans by Recruiting Capillaries by Asmar, Meena, Asmar, Ali, Simonsen, Lene, Holst, Jens Juul, Bülow, Jens

    “…Context and Objective: Glucose-dependent insulinotropic polypeptide (GIP) in combination with hyperinsulinemia increases blood flow and triglyceride clearance…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients by Kielgast, Urd, Asmar, Meena, Madsbad, Sten, Holst, Jens J.

    “…Context: The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin…”
    Get full text
    Journal Article